Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
NurExone Biologic: Technisches (täglich, wöchentlich, monatlich) & Analysten "Strong Buy"-Rating!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PBJC | ISIN: US03837C1062 | Ticker-Symbol: BOV
Frankfurt
28.03.24
16:51 Uhr
1,210 Euro
+0,080
+7,08 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
APYX MEDICAL CORPORATION Chart 1 Jahr
5-Tage-Chart
APYX MEDICAL CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
1,2201,30028.03.
1,2401,30028.03.

Aktuelle News zur APYX MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.03.Earnings call: Apyx Medical reports growth amid market challenges5
21.03.Apyx Medical Corp - 10-K, Annual Report1
21.03.Apyx Medical reports mixed Q4 results; initiates FY24 outlook2
21.03.Apyx Medical Corp - 8-K, Current Report1
21.03.Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook98CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed...
► Artikel lesen
20.03.Apyx Medical's Earnings: A Preview1
21.02.Apyx Medical Corp - 8-K, Current Report1
22.01.Apyx Medical Corp - 8-K, Current Report1
08.01.Apyx Medical's Q4 revenue to be below consensus1
08.01.Apyx Medical Corp - 8-K, Current Report1
08.01.Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results100CLEARWATER, Fla.--(BUSINESS WIRE)--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®...
► Artikel lesen
14.12.23Apyx Medical finance chief buys 2.5K common shares1
28.11.23Apyx Medical Corp - 8-K, Current Report-
28.11.23Apyx Medical Appoints Matthew Hill As Chief Financial Officer2
28.11.23Apyx Medical appoints Matthew Hill as CFO1
16.11.23Apyx Medical Corp - 8-K, Current Report1
16.11.23Apyx Medical Corp - S-8, Securities to be offered to employees in employee benefit plans1
16.11.23Apyx Medical says CEO Goodwin buys 50K shares in co1
16.11.23Massive Insider Trade At Apyx Medical1
16.11.23Insiders Buying Apyx Medical And 3 Other Stocks Under $31
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1